HPV (Human Papillomavirus)-Associated
7
4
4
1
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 60/100
14.3%
1 terminated out of 7 trials
50.0%
-36.5% vs benchmark
0%
0 trials in Phase 3/4
100%
1 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (7)
Parent Education About Human Papillomavirus (HPV)
Evaluation of the Q-Pad hrHPV Test System for Identifying Precancer
The Effect of HPV Education Provided to Women on Their Knowledge Levels, HPV Screening, and Vaccination Uptake
Multicenter Prospective Non-randomized Controlled Study of Ella Photodynamic Therapy for Cervical HSIL/CIN2
Vaccination Against Human Papillomavirus (HPV) After Allogeneic Stem Cell Transplantation
The Effect of Natural Molecules on HPV Infection
OPSCC N0 Nodal Control With Reduced IMRT